According to the research report, the global 3Dprinting medical implants market size is expected to touch USD 9064.9 million by 2030, from USD 1,592.6 million in 2020, growing with a significant CAGR of 19% from 2021 to 2030.
The 3D printing medical implants market report
offers a comprehensive study of the current state expected at the major
drivers, market strategies, and key vendors’ growth. The report presents
energetic visions to conclude and study the market size, market hopes, and
competitive surroundings. The research also focuses on the important
achievements of the market, research & development, and regional growth of
the leading competitors operating in the market. The current trends of the
global 3D printing medical implants market in conjunction with the geographical
landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global 3D printing medical implants market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global 3D printing medical implants market during the
forecast period. It also includes a key indicator assessment that highlights
growth prospects of this market and estimates statistics related to growth of
the market in terms of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/1231
Report Scope of the 3D Printing Medical Implants Market
Report Highlights | Details |
Market Size | USD 9069.9 Million by 2030 |
Growth Rate | CAGR of 19% From 2022 to 2030 |
Base Year | 2021 |
Historic Data | 2017 to 2021 |
Forecast Period | 2022 to 2030 |
Segments Covered | Component, Application, End user, Technology |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
This study covers a detailed segmentation
of the global 3D printing medical implants market, along with key information
and a competition outlook. The report mentions company profiles of players that
are currently dominating the global 3D printing medical implants market,
wherein various developments, expansions, and winning strategies practiced and
implemented by leading players have been presented in detail.
Key Players
- 3D Bioprinting Solutions
- BioBots
- ANDREAS STIHL AG & Co. KG
- Aspect Biosystems
- Formlabs
- Medprin
- Stratasys
- Organovo
- Rokit
- Materialise N.V.
- Cyfuse Biomedical
Market Segmentation
By Component
- Material
- Service
- System
By Application
- Dental
- Orthopedic
- Cranial
- Others
By End user
- Pharmaceutical & biopharmaceutical companies
- Academic institutions
- Surgical centers
By Technology
- Laser beam melting
- Electronic beam melting
- Droplet deposition
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- United Kingdom
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
Research Methodology
The research methodology adopted by
analysts for compiling the global 3D printing medical implants market report is
based on detailed primary as well as secondary research. With the help of
in-depth insights of the market-affiliated information that is obtained and
legitimated by market-admissible resources, analysts have offered riveting
observations and authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary
understanding of the global 3D printing medical implants market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. 3D Printing in Medical Implants Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on 3D Printing in Medical Implants Market
5.1. Covid-19: 3D Printing in Medical Implants Industry Impact
5.2. 3D Printing in Medical Implants Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and 3D Printing in Medical Implants Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for 3D Printing in Medical Implants Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. 3D Printing in Medical Implants Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing technological advances in 3D printed implants
6.1.1.2. Increase in healthcare expenditure and rise in R&D investment
6.1.1.3. Surge in number of medical surgeries
6.1.2. Market Restraints
6.1.2.1. High cost of printers
6.1.3. Market Opportunities
6.1.3.1. Emerging markets
Chapter 7. Global 3D Printing in Medical Implants Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. 3D Printing in Medical Implants Market Revenue by Market Players (2017 - 2020)
7.1.1.2. 3D Printing in Medical Implants Market Revenue Market Share by Market Players (2017 - 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter 8. Global 3D Printing in Medical Implants Market, By Component
8.1. 3D Printing in Medical Implants Market, by Component, 2017-2030
8.1.1. Material
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Service
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. System
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global 3D Printing in Medical Implants Market, By Applications
9.1. 3D Printing in Medical Implants Market, by Applications, 2017-2030
9.1.1. Dental
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Orthopedic
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Cranial
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global 3D Printing in Medical Implants Market, By Technology
10.1. 3D Printing in Medical Implants Market, by Technology, 2017-2030
10.1.1. Laser beam melting
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Electronic beam melting
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Droplet deposition
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global 3D Printing in Medical Implants Market, By End user
11.1. 3D Printing in Medical Implants Market, by End user, 2017-2030
11.1.1. Pharmaceutical & biopharmaceutical companies
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Academic institutions
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Surgical centers
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global 3D Printing in Medical Implants Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue Forecast by Component(2017-2030)
12.1.2. Market Revenue Forecast by Application (2017-2030)
12.1.3. Market Revenue Forecast by Technology (2017-2030)
12.1.4. Market Revenue Forecast by End user (2017-2030)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2017-2030)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2017-2030)
12.2. Europe
12.2.1. Market Revenue Forecast by Component (2017-2030)
12.2.2. Market Revenue Forecast by Application (2017-2030)
12.2.3. Market Revenue Forecast by Technology (2017-2030)
12.2.4. Market Revenue Forecast by End user (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2017-2030)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2017-2030)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Component (2017-2030)
12.3.2. Market Revenue Forecast by Application (2017-2030)
12.3.3. Market Revenue Forecast by Technology (2017-2030)
12.3.4. Market Revenue Forecast by End user (2017-2030)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2017-2030)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2017-2030)
12.4. LATAM
12.4.1. Market Revenue Forecast by Component (2017-2030)
12.4.2. Market Revenue Forecast by Application (2017-2030)
12.4.3. Market Revenue Forecast by Technology (2017-2030)
12.4.4. Market Revenue Forecast by End user (2017-2030)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2017-2030)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2017-2030)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Component (2017-2030)
12.5.2. Market Revenue Forecast by Application (2017-2030)
12.5.3. Market Revenue Forecast by Technology (2017-2030)
12.5.4. Market Revenue Forecast by End user (2017-2030)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2017-2030)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2017-2030)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2017-2030)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2017-2030)
Chapter 13. Company Profiles
13.1. 3D Bioprinting Solutions
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2017-2020)
13.1.4. Recent Developments and Strategies
13.2. Aspect Biosystems
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2017-2020)
13.2.4. Recent Developments and Strategies
13.3. BioBots
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2017-2020)
13.3.4. Recent Developments and Strategies
13.4. Cyfuse Biomedical
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2017-2020)
13.4.4. Recent Developments and Strategies
13.5. Formlabs
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2017-2020)
13.5.4. Recent Developments and Strategies
13.6. Materialise N.V.
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2017-2020)
13.6.4. Recent Developments and Strategies
13.7. Medprin
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2017-2020)
13.7.4. Recent Developments and Strategies
13.8. Organovo
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2017-2020)
13.8.4. Recent Developments and Strategies
13.9. Rokit
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2017-2020)
13.9.4. Recent Developments and Strategies
13.10. Stratasys
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2017-2020)
13.10.4. Recent Developments and Strategies
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments